You are here: All Products  > SciClone Pharma Gains China Rights for Two CV Drugs in $50 Million Deal

SciClone Pharma Gains China Rights for Two CV Drugs in $50 Million Deal

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products